Related Experiment Video
Updated: Jun 23, 2026

Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
3',4'-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta
Owen L Woodman1, Wachirawadee Malakul
1School of Medical Sciences, RMIT University, Bundoora, Victoria 3083, Australia. owen.woodman@rmit.edu.au
The antioxidant 3
Area of Science:
- Biochemistry
- Physiology
- Pharmacology
Background:
- Diabetes mellitus is associated with increased oxidative stress.
- Oxidative stress impairs endothelium-dependent relaxation in blood vessels.
Purpose of the Study:
- To investigate the effects of the antioxidant 3',4'-dihydroxyflavonol (DiOHF) on superoxide release and endothelial function in diabetic rat aortae.
Main Methods:
- Type-1 diabetes was induced in rats using streptozotocin (STZ).
- Vascular reactivity and superoxide generation were assessed in aortic rings using organ bath techniques and lucigenin-enhanced chemiluminescence.
Main Results:
- Diabetic rats exhibited elevated blood glucose and increased aortic superoxide generation compared to controls.
- Acetylcholine-induced relaxation was impaired in diabetic aortae, while relaxation to sodium nitroprusside was unaffected.
- Acute exposure to DiOHF reduced superoxide generation and enhanced acetylcholine-induced relaxation in diabetic aortae.
- One-week in vivo treatment with DiOHF also reduced superoxide generation and improved endothelial function in diabetic rats.
Conclusions:
- The antioxidant DiOHF effectively reduces oxidant stress in diabetic rat aortae.
- DiOHF preserves endothelium-dependent relaxation in the vasculature of diabetic rats, both acutely and after short-term in vivo treatment.
More Related Videos
07:53Standardized Rat Coronary Ring Preparation and Real-Time Recording of Dynamic Tension Changes Along Vessel Diameter
Published on: June 16, 2022
08:15Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
Published on: May 10, 2024
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Diabetic Retinopathy
Diabetic Nephropathy
Type II Diabetes II: Pathophysiology